Physics

U. Amaldi, W. de Boer, H. Furstenau, "Comparison of grand unified theories with electroweak and strong coupling constants measured at LEP," Physics Letters B, 260:447-55, 1991. Ugo Amaldi (CERN, Geneva): "Unifying all forces in nature into a single theory has been the dream of many physicists, including Einstein. "Since LEP--the powerful electron-positron collider at CERN, Europe's laboratory for particle physics--has begun operating, physicists have got some hint that, indeed, all forces

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

U. Amaldi, W. de Boer, H. Furstenau, "Comparison of grand unified theories with electroweak and strong coupling constants measured at LEP," Physics Letters B, 260:447-55, 1991.

Ugo Amaldi (CERN, Geneva): "Unifying all forces in nature into a single theory has been the dream of many physicists, including Einstein.

"Since LEP--the powerful electron-positron collider at CERN, Europe's laboratory for particle physics--has begun operating, physicists have got some hint that, indeed, all forces might have been unified during the very first moment of the creation of the universe, the Big Bang, when particles supposedly interacted with each other at energies well above 10-16 GeV.

"It turns out that the precise data from LEP exclude unification within the standard model of the strong, electromagnetic, and weak force: In this model the extrapolation of the strengths of these three forces from LEP energies to Big Bang energies shows that they never were all equally ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies